ונטולין משאף ללא CFC
Land: Ísrael
Tungumál: hebreska
Heimild: Ministry of Health
Upplýsingar fylgiseðill
(PIL)
13-12-2023
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
SALBUTAMOL AS SULFATE
Fáanlegur frá:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC númer:
R03AC02
Lyfjaform:
משאף
Samsetning:
SALBUTAMOL AS SULFATE 100 MCG/DOSE
Stjórnsýsluleið:
שאיפה
Gerð lyfseðils:
מרשם נדרש
Framleitt af:
GLAXO WELLCOME SA, SPAIN
Meðferðarhópur:
SALBUTAMOL
Lækningarsvæði:
SALBUTAMOL
Ábendingar:
Ventolin Inhaler is a short-acting bronchodilator with fast onset in reversible airways obstruction. It is particularly suitable for the relief and prevention of asthma symptoms.It should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognized by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).
Leyfisdagur:
2023-01-31
Upplýsingar fylgiseðill
" )
(
–
1986
CFC : )
(
100
/"
SALBUTAMOL (AS SULFATE) 100 MCG/DOSE
,
6
–
."
"
.
.
,
.
.
.
.
1
.
?
(
4-6
(
,)
5
.
)
.
.)
(
,
,
. :
-
2
.
.
.
,
•
.
•
.
,
HFA 134a
.
.
.
.
2
. :
•
)
(
(
6
.) : ,
•
(
.)
.
•
.
•
.
•
,
.
•
)
(
.
•
,
.
/
. ,
:
•
)
(
.
•
.
,
.
,
,
.
.
3
.
?
.
.
.
:
12
•
-
.
•
-
10-15
.
•
-
4
.
•
8
24
.
12
•
-
.
.
•
-
10-15
.
.
•
-
4
.
•
8
24
.
•
,
,)
(
5
.
.
.
.
,
.
:
•
•
•
)
(
.
,
.
,
.
,
.
.
,
.
.
, ! .
.
. ,
4
. ,
, .
,
.
.
.
:
(
-
1
10,000
)
,
.
,
,
,
:
,
,
. :
•
.)
(
,
•
•
-
1
10
.
.
,
.
,
:
-
1
10
:
•
•
.
-
1
100
:
•
•
.
-
1
1,000
:
•
•
)
(
.
-
1
10,000
:
•
,
. :
•
)
(
.
.
.
,
.
.
. , . ,
"
"
)
ww.health.gov.il
w
)
:
"
,
https://sideeffects.health.gov.il
/
5
.
?
•
!
.
/
.
•
(
(exp. date
.
.
•
-
°C
30
.
.
•
,
.
.
•
.
-
°C
50
,
.
.
•
.
.
.
6
.
•
,
:
HFA 134a
.
•
:
.
,
200
)
(
100
.
•
:
' ,
"
)
(
25
.
,
•
:
S.A.
.
,
,
•
:
113-25-29560
.
•
,
.
,
. :
•
,
.
.
,
.
•
200
.
.
,
.
.
.
1
.
,
.
.
2
.
,
,
.
5
,
.
.
1
.
.
2
.
.)
(
.
3
.
4
5
.
4
.
.
,
.
.
5
.
.
.
.
6
.
.
,
.
.
7
.
,
.
.
,
8
.
,
7
-
3
.
9
.
.
.
'
'
.
.
.
.
.
,
,)
(
5
.
.
.
.
,
,
.
.
,
:
•
.
•
.
•
.
•
.
.
_ _
2023
.
GSK
.
©
2023
GSK
.
_Ven Inh PT V7 _
_ _
_ _
Lestu allt skjalið
